Works matching DE "BRUTON tyrosine kinase"
Results: 787
A Structure‐Activity Investigation of the Fungal Metabolite (−)‐TAN‐2483B: Inhibition of Bruton's Tyrosine Kinase.
- Published in:
- Chemistry - A European Journal, 2024, v. 30, n. 35, p. 1, doi. 10.1002/chem.202401051
- By:
- Publication type:
- Article
Scaffold‐Oriented Asymmetric Catalysis: Conformational Modulation of Transition State Multivalency during a Catalyst‐Controlled Assembly of a Pharmaceutically Relevant Atropisomer.
- Published in:
- Chemistry - A European Journal, 2024, v. 30, n. 30, p. 1, doi. 10.1002/chem.202401109
- By:
- Publication type:
- Article
Comparative arrhythmia patterns among patients on tyrosine kinase inhibitors.
- Published in:
- Journal of Interventional Cardiac Electrophysiology, 2024, v. 67, n. 1, p. 111, doi. 10.1007/s10840-023-01575-z
- By:
- Publication type:
- Article
BTK inhibition limits B-cell–T-cell interaction through modulation of B-cell metabolism: implications for multiple sclerosis therapy.
- Published in:
- Acta Neuropathologica, 2022, v. 143, n. 4, p. 505, doi. 10.1007/s00401-022-02411-w
- By:
- Publication type:
- Article
Severe Hyperglycemia Due to Protein Kinase Inhibitor Therapy in a Patient With Poorly Controlled Diabetes Mellitus.
- Published in:
- JCEM Case Reports, 2024, v. 2, n. 1, p. 1, doi. 10.1210/jcemcr/luad172
- By:
- Publication type:
- Article
The kinase Btk negatively regulates the production of reactive oxygen species and stimulation-induced apoptosis in human neutrophils.
- Published in:
- Nature Immunology, 2012, v. 13, n. 4, p. 369, doi. 10.1038/ni.2234
- By:
- Publication type:
- Article
Bruton's tyrosine kinase inhibitors in the treatment of multiple sclerosis.
- Published in:
- Postepy Psychiatrii i Neurologii / Advances in Psychiatry & Neurology, 2023, v. 32, n. 1, p. 23, doi. 10.5114/ppn.2023.126319
- By:
- Publication type:
- Article
Regulation of Cx43 Gap Junction Intercellular Communication by Bruton's Tyrosine Kinase and Interleukin-2-Inducible T-Cell Kinase.
- Published in:
- Biomolecules (2218-273X), 2023, v. 13, n. 4, p. 660, doi. 10.3390/biom13040660
- By:
- Publication type:
- Article
Illuminating spatial pharmacology with in situ drug imaging.
- Published in:
- Clinical & Translational Medicine, 2022, v. 12, n. 8, p. 1, doi. 10.1002/ctm2.1024
- By:
- Publication type:
- Article
Comparison of the blood immune repertoire with clinical features in chronic lymphocytic leukemia patients treated with chemoimmunotherapy or ibrutinib.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1302038
- By:
- Publication type:
- Article
Case report: Successful treatment of refractory immune thrombocytopenia in chronic lymphocytic leukaemia with venetoclax monotherapy.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1260003
- By:
- Publication type:
- Article
Overcoming the therapeutic limitations of EZH2 inhibitors in Burkitt's lymphoma: a comprehensive study on the combined effects of MS1943 and Ibrutinib.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1252658
- By:
- Publication type:
- Article
Preclinical investigations of the efficacy of the glutaminase inhibitor CB-839 alone and in combinations in chronic lymphocytic leukemia.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1161254
- By:
- Publication type:
- Article
Zanubrutinib for the treatment of lymphoid malignancies: Current status and future directions.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1130595
- By:
- Publication type:
- Article
Paradoxical activation of chronic lymphocytic leukemia cells by ruxolitinib in vitro and in vivo.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1043694
- By:
- Publication type:
- Article
A novel inflammation-related prognostic model for predicting the overall survival of primary central nervous system lymphoma: A real-world data analysis.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1104425
- By:
- Publication type:
- Article
Case report: Successful management of a refractory double-expressor diffuse large B-cell lymphoma patient under the guidance of in vitro high-throughput drug sensitivity test.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2022.1079890
- By:
- Publication type:
- Article
Real-world treatment patterns, discontinuation and clinical outcomes in patients with B-cell lymphoproliferative diseases treated with BTK inhibitors in China.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1184395
- By:
- Publication type:
- Article
Research-based flow cytometry assays for pathogenic assessment in the human B-cell biology of gene variants revealed in the diagnosis of inborn errors of immunity: a Bruton’s tyrosine kinase case-study.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1095123
- By:
- Publication type:
- Article
Zanubrutinib plus salvage chemotherapy for relapsed or refractory diffuse large B-cell lymphoma.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1015081
- By:
- Publication type:
- Article
Case report: A rare case of coexisting Waldenstrom Macroglobulinemia and B-cell acute lymphoblastic leukemia with KMT2D and MECOM mutations.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1001482
- By:
- Publication type:
- Article
Case report: CD19-directed CAR-T cell therapy combined with BTK inhibitor and PD-1 antibody against secondary central nervous system lymphoma.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.983934
- By:
- Publication type:
- Article
Risk of HBV reactivation in relapsed or refractory diffuse large B-cell lymphoma patients receiving Bruton tyrosine kinase inhibitors therapy.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 01, doi. 10.3389/fimmu.2022.982346
- By:
- Publication type:
- Article
Effects of ibrutinib on T-cell immunity in patients with chronic lymphocytic leukemia.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 01, doi. 10.3389/fimmu.2022.962552
- By:
- Publication type:
- Article
Case Report: Dual Inhibition of HDAC and BTK for Diffuse Large B-Cell Lymphoma After Failure to CD19-Targeted CAR-T Therapy.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.894787
- By:
- Publication type:
- Article
Passengers, drivers, and "goners".
- Published in:
- International Journal of Cancer, 2024, v. 155, n. 9, p. 1696, doi. 10.1002/ijc.35112
- By:
- Publication type:
- Article
Treatment patterns and clinical outcomes of mantle cell lymphoma: A retrospective cohort study by CHOICE.
- Published in:
- International Journal of Cancer, 2023, v. 153, n. 5, p. 1016, doi. 10.1002/ijc.34565
- By:
- Publication type:
- Article
STUDIES OF QUANTUM MECHANICS/MOLECULAR DOCKING ON ZANUBRUTINIB AS POTENTIAL REPURPOSED AGAINST COVID-19.
- Published in:
- Bulletin of the Chemical Society of Ethiopia, 2022, v. 36, n. 2, p. 479, doi. 10.4314/bcse.v36i2.19
- By:
- Publication type:
- Article
Resisting the Resistance: Navigating BTK Mutations in Chronic Lymphocytic Leukemia (CLL).
- Published in:
- Genes, 2023, v. 14, n. 12, p. 2182, doi. 10.3390/genes14122182
- By:
- Publication type:
- Article
Assessment of Seasonality in Eosinophilic Dermatosis of Haematological Malignancy.
- Published in:
- Acta Dermato-Venereologica, 2024, v. 104, p. 1, doi. 10.2340/actadv.v104.15768
- By:
- Publication type:
- Article
Real-World Comparison of First-Line Treatment Adherence Between Single-Agent Ibrutinib and Acalabrutinib in Patients with Chronic Lymphocytic Leukemia.
- Published in:
- Patient Preference & Adherence, 2023, v. 17, p. 2073, doi. 10.2147/PPA.S417180
- By:
- Publication type:
- Article
Another Perspective on Cardio-Oncology: Insights from Houston, Texas.
- Published in:
- Romanian Journal of Cardiology, 2024, v. 34, n. 4, p. 165, doi. 10.2478/rjc-2024-0032
- By:
- Publication type:
- Article
The conundrum of below the knee (BTK) drug delivery.
- Published in:
- Vascular Medicine, 2023, v. 28, n. 6, p. 581, doi. 10.1177/1358863X231204626
- By:
- Publication type:
- Article
Utility of Bruton's Tyrosine Kinase Inhibitors in Light Chain Amyloidosis Caused by Lymphoplasmacytic Lymphoma (Waldenström's Macroglobulinemia).
- Published in:
- 2022
- By:
- Publication type:
- Case Study
What is novel in the clinical management of pemphigus vulgaris?
- Published in:
- Expert Review of Clinical Pharmacology, 2024, v. 17, n. 5/6, p. 489, doi. 10.1080/17512433.2024.2350943
- By:
- Publication type:
- Article
Risk of bleeding associated with BTK inhibitor monotherapy: a systematic review and meta-analysis of randomized controlled trials.
- Published in:
- Expert Review of Clinical Pharmacology, 2022, v. 15, n. 8, p. 987, doi. 10.1080/17512433.2022.2106968
- By:
- Publication type:
- Article
Abstracts from the 13th International Conference for Healthcare and Medical Students (ICHAMS).
- Published in:
- 2025
- Publication type:
- Abstract
Biological drugs for the treatment of children with chronic spontaneous urticaria.
- Published in:
- Expert Review of Clinical Immunology, 2024, v. 20, n. 12, p. 1427, doi. 10.1080/1744666X.2024.2388689
- By:
- Publication type:
- Article
Biologics for chronic spontaneous urticaria: toward a personalized treatment.
- Published in:
- Expert Review of Clinical Immunology, 2022, v. 18, n. 12, p. 1297, doi. 10.1080/1744666X.2022.2138347
- By:
- Publication type:
- Article
Background and Clinical Features of a Unique and Mysterious Autoinflammatory Disease, Schnitzler Syndrome.
- Published in:
- International Journal of Molecular Sciences, 2025, v. 26, n. 2, p. 598, doi. 10.3390/ijms26020598
- By:
- Publication type:
- Article
Molecular Composition and Kinetics of B Cells During Ibrutinib Treatment in Patients with Chronic Lymphocytic Leukemia.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 23, p. 12569, doi. 10.3390/ijms252312569
- By:
- Publication type:
- Article
Estimating the Number of Polygenic Diseases Among Six Mutually Exclusive Entities of Non-Tumors and Cancer.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 22, p. 11968, doi. 10.3390/ijms252211968
- By:
- Publication type:
- Article
Benefits and Challenges of Drug-Coated Balloons in Peripheral Artery Disease: From Molecular Mechanisms to Clinical Practice.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 16, p. 8749, doi. 10.3390/ijms25168749
- By:
- Publication type:
- Article
Labeling of Bruton's Tyrosine Kinase (BTK) Inhibitor [ 11 C]BIO-2008846 in Three Different Positions and Measurement in NHP Using PET.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 14, p. 7870, doi. 10.3390/ijms25147870
- By:
- Publication type:
- Article
The Evolving Role of Bruton's Tyrosine Kinase Inhibitors in B Cell Lymphomas.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 14, p. 7516, doi. 10.3390/ijms25147516
- By:
- Publication type:
- Article
Arrhythmogenic Ventricular Remodeling by Next-Generation Bruton's Tyrosine Kinase Inhibitor Acalabrutinib.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 11, p. 6207, doi. 10.3390/ijms25116207
- By:
- Publication type:
- Article
Liver Diseases: From Bench to Bedside.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 10, p. 5454, doi. 10.3390/ijms25105454
- By:
- Publication type:
- Article
A Review of Resistance Mechanisms to Bruton's Kinase Inhibitors in Chronic Lymphocytic Leukemia.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 10, p. 5246, doi. 10.3390/ijms25105246
- By:
- Publication type:
- Article
Targeting BTK in B Cell Malignancies: From Mode of Action to Resistance Mechanisms.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 6, p. 3234, doi. 10.3390/ijms25063234
- By:
- Publication type:
- Article
Bruton's Tyrosine Kinase Inhibitors: Recent Updates.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 4, p. 2208, doi. 10.3390/ijms25042208
- By:
- Publication type:
- Article